Access & Prescribing (Australia & Global)
Federal Schedule III Reclassification Prompts State-Level Medical Cannabis Expansion and Regulatory Adjustments
Explore how the federal reclassification of medical cannabis to Schedule III is driving significant state-level regulatory changes, fostering medical cann…
Access & Prescribing (Australia & Global)
CSQ Introduces EU GMP Addendum to Facilitate Cannabinoid Export Compliance for European Markets
A new EU GMP Addendum from CSQ aims to help global cannabinoid producers meet European medical cannabis market standards, addressing compliance and supply…
Australian Cannabis Policy & Law
U.S. House Advances Farm Bill, Establishing Separate Regulatory Pathways for Industrial Hemp and Cannabinoid Crops
The U.S. House passed the Farm, Food, and National Security Act of 2026, establishing distinct regulatory frameworks for industrial hemp and cannabinoid c…
Access & Prescribing (Australia & Global)
Exploring Medical Cannabis for Seniors: Enhancing Quality of Life in Later Years
Discover how medical cannabis may support seniors managing chronic pain, anxiety, and insomnia, potentially reducing reliance on multiple pharmaceuticals.…
Cannabinoid Pharmacology
Study Highlights Adverse Events Associated with Medical Cannabis Use in Minnesota Program
A new study on medical cannabis adverse events in Minnesota reveals that while infrequent, they can lead to treatment discontinuation. Learn about reporte…
Australian Cannabis Policy & Law
DEA Classifies Synthetic Cannabinoid HHC as Schedule I Substance; Texas Hemp Sales Face New Rulings
The DEA has clarified HHC legality, classifying the synthetic cannabinoid hexahydrocannabinol as a Schedule I substance. Learn how this impacts the hemp i…
Access & Prescribing (Australia & Global)
Australian Medical Cannabis Sales Decline 28.5% Amid Increased Regulatory Enforcement
Australian medical cannabis sales decreased 28.5% in H2 2025, the first significant drop since 2016. Discover how increased regulatory enforcement by the…
Access & Prescribing (Australia & Global)
Israel Health Ministry Proposes Significant Tightening of Medical Cannabis Regulation
Israel's Health Ministry proposes a major overhaul of its medical cannabis regulation, including a phased ban on smoked products and stricter prescribing…
Access & Prescribing (Australia & Global)
Warrnambool Driver Retains Licence Following Medical Cannabis Prescription Defence
A Warrnambool Magistrates Court decision allowed a driver to retain his licence after presenting a valid medical cannabis prescription, highlighting legal…
Cannabinoid Pharmacology
Research Explores Saussurea Costus Compounds for Rheumatoid Arthritis Inflammation
New research published in Frontiers in Pharmacology investigates Saussurea costus, a traditional Chinese medicine plant, for its anti-inflammatory compoun…
